ARTICLE | Clinical News
Accolate zafirlukast regulatory update
March 31, 2008 7:00 AM UTC
FDA said it is reviewing postmarketing reports of behavior and mood changes, suicidality and suicide in Accolate zafirlukast from AstraZeneca and Zyflo zileuton and Zyflo CR from Critical Therapeutics...